Tag: opiate manufacturing facilities
Sun Pharma completes acquisition of GSK’s opiate business in Australia
Sun Pharma, the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company, has announced the successful acquisition of GSK’s opiates business...
Featured Article
Navigating energy price volatility with predictive intelligence
Energy price volatility has become a structural feature of modern electricity markets rather than a temporary disruption. For energy-intensive manufacturers and large commercial operators, fluctuating wholesale prices are reshaping how energy costs are managed, making reactive approaches increasingly inadequate.
